WHO ICTRP trial
European ADHD in substance use disorders prevalence study.
NL-OMON33223 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON33223 |
|---|---|
| Public title | European ADHD in substance use disorders prevalence study. |
| Scientific title | European ADHD in substance use disorders prevalence study. - EASP study |
| Primary sponsor | Arkin (Amsterdam) |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | verslaving ADHD attention deficit disorder with hyperactivity;10009841;ADHD;attention deficit disorder with hyperactivity |
| Interventions | ;ADHD;comorbidity;substance use disorder |
| Registration date | Jan 12, 2010 |
| Target size | 500 |
| Secondary IDs | NL28206.097.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: